Lozol contains indapamide, a thiazide-like diuretic used primarily for hypertension and in selected circumstances for fluid-related conditions, with a long-lasting blood-pressure effect but clinically relevant risks of sodium or potassium depletion, postural symptoms and interactions that require a review of kidney function and the exact tablet formulation.
Key Points
- Indapamide is thiazide-like rather than chemically identical to hydrochlorothiazide.
- Indapamide is supplied in 1.5 mg and 2.5 mg presentations in some markets, but release characteristics also affect substitution.
- Low sodium and low potassium are important potential treatment complications.
- Older adults can be especially vulnerable to thiazide-related hyponatremia and falls.
- Indapamide has both natriuretic and vascular effects relevant to blood-pressure reduction.
Indapamide Is Not Hydrochlorothiazide
The two medicines are used for hypertension but differ in pharmacology, duration and available presentations. Indapamide has important vascular effects alongside its influence on renal sodium handling. Direct tablet-for-tablet substitution does not respect the differences in dose and release design.
Indapamide is sometimes described as a diuretic, but its long-term antihypertensive activity also involves blood-vessel effects. The precise benefit for an individual depends on the dose, other medicines and underlying cardiovascular risk. Comparing it with another thiazide-related drug requires attention to patient outcomes as well as the degree of urination.
Modified Release and Conventional Tablets
Some countries market indapamide in immediate-release and sustained-release preparations. A label stating 1.5 mg may indicate a modified-release formulation rather than a weaker copy of a 2.5 mg conventional tablet. The exact release description matters when filling a prescription.
Modified-release tablets are designed to change the rate of delivery. A 1.5 mg indapamide product may use such a formulation, whereas 2.5 mg products may have different release behavior. A person moving between pharmacy suppliers should verify the label rather than assume that taking more or fewer tablets reproduces the same exposure.
Why Sodium Is Often the First Concern
Thiazide-like medicines can cause low sodium, particularly in older adults and patients consuming excess free water relative to solute. Fatigue, headache or confusion may develop gradually. Blood-pressure improvement does not exclude an electrolyte complication.
Low sodium may produce vague complaints such as tiredness, headache or difficulty concentrating before more dramatic symptoms occur. For older adults, it can contribute to falls or confusion. The value of laboratory monitoring is that it detects an emerging problem that would not necessarily be apparent from blood-pressure measurements alone.
Potassium Loss and the Heart
Indapamide may lower potassium and magnesium, which can contribute to weakness and arrhythmia risk. The concern increases when another medicine prolongs the QT interval or when gastrointestinal illness causes further loss of electrolytes.
Electrolyte losses are particularly relevant in a person also receiving a medicine that affects cardiac repolarization. Low potassium may increase susceptibility to rhythm disturbance. A new episode of palpitations or unexplained weakness should prompt assessment, with a review of whether vomiting, diarrhea or another diuretic is contributing.
Renal Disease and Fluid Status
Kidney function helps determine whether a diuretic can be used safely and effectively. Low blood pressure during illness, dehydration or significant decline in kidney function may require temporary regimen review. A refill should not continue automatically after an admission for electrolyte disturbance.
During an acute illness, the same antihypertensive dose may produce a different effect because fluid intake and kidney perfusion have changed. The patient should discuss severe dehydration or sustained low blood pressure with the medical team. The aim is to avoid kidney injury and dangerous electrolyte shifts while preserving long-term cardiovascular treatment.
Older Adults and Falls
Postural dizziness and reduced balance can reflect treatment effects, low sodium or an interaction among several antihypertensives. When a patient reports new falls, measuring sitting and standing blood pressure and checking electrolytes may be more useful than simply advising greater caution.
Dizziness when standing may be attributed to age, but medications and sodium balance can contribute. A clinician may compare seated and standing blood pressure and ask about the time of the last dose. Changes to footwear or walking habits do not address a reversible medication-related cause of repeated falls.
Like other thiazide-related therapies, indapamide can affect uric acid and glucose in some patients. The risk-benefit decision also considers stroke prevention and blood-pressure control. Medical review is preferable to stopping treatment after seeing one minor laboratory change.
Uric acid and glucose results sometimes change on thiazide-like treatment. The prescriber considers whether those changes are clinically significant and whether alternative agents fit the patient’s cardiovascular profile. A patient with a history of painful gout attacks should report that history before indapamide is prescribed.
What to Compare Between Packages
Lozol, indapamide and national branded products may differ in strength, release type and dosage instructions. The name and number on the front of the box are not a sufficient substitution check without confirming the full presentation.
When comparing Lozol with generic indapamide, the formulation is as important as the strength. Release technology and the intended administration schedule need to match. The quantity displayed on a website cannot explain a prescription discrepancy and should not determine a change in how the medicine is taken.
The Patient Who Feels Well but Has Low Sodium
Thiazide-related hyponatremia may develop with relatively nonspecific symptoms and sometimes appears on routine testing before dramatic complaints arise. Older adults can be particularly vulnerable. A normal blood-pressure reading does not exclude a dangerous electrolyte change. The prescriber may need to review water intake, other medications and the onset of weakness or confusion.
Lozol and generic indapamide products may differ by release formulation. In some markets the 1.5 mg modified-release product is not a straightforward substitute for a conventional 2.5 mg tablet. Patients should compare the full label, including release characteristics, rather than assuming that two strengths can be made equivalent by cutting tablets or changing frequency.
Diuretic Treatment During Illness
Vomiting, fever or reduced fluid intake may change the balance between blood-pressure benefit and dehydration risk. Kidney function and electrolytes can deteriorate while a patient feels only mildly weak. A clinician should advise how to manage the existing regimen during significant illness. Taking additional tablets to deal with ankle swelling could make the imbalance worse.
Low potassium and magnesium can affect the heart’s electrical function. An episode of palpitations, faintness or marked weakness deserves review of electrolytes and interacting medicines. Other drugs that prolong the QT interval may add concern. A patient should describe the timing of symptoms and any recent vomiting or diarrhea instead of assuming the symptoms are caused only by anxiety.
Dizziness on standing may reflect a blood-pressure drop, electrolyte disturbance or another illness. The clinical team can check postural blood-pressure measurements and recent lab results. The goal is to preserve cardiovascular protection without creating repeated falls or confusion. Changing the dose without supervision can also produce rebound hypertension or loss of control.
Indapamide has a sustained antihypertensive effect, but that does not eliminate the possibility of electrolyte depletion or excessive blood-pressure lowering. Older patients, people with low baseline sodium and those taking other medicines associated with hyponatremia may need particular attention. A persistent dry mouth, new confusion, unusual fatigue or unsteady walking can signal a problem that does not resemble an ordinary blood-pressure symptom. A clinician may check sodium, potassium and kidney function after initiation and during subsequent changes. The relevant question is whether the regimen controls pressure without producing avoidable harm, not whether a tablet is labeled as a mild diuretic. Continued monitoring helps answer that question over months.
Lozol is a brand associated with indapamide, a thiazide-like diuretic used in selected blood-pressure regimens. The catalog shows 1.5 mg and 2.5 mg options ranging from $42.99 to $399.99. Those strengths may involve different release characteristics, which cannot be inferred from the number alone. A modified-release formulation and a conventional tablet should be checked against the actual prescription before considering either as a replacement for the other. The clinical target is sustained blood-pressure control with acceptable electrolyte results, not increased urine output for its own sake.
Hyponatremia can develop with indapamide and may present as weakness, confusion or falls, especially among older people. Potassium and kidney function also require attention, and a new illness or hot-weather dehydration can upset a previously stable regimen. A pharmacist reviewing a refill should ask whether the patient uses other antihypertensives and whether the last electrolyte test was satisfactory. If a patient feels dizzy on standing, simply reducing tablets without medical advice may miss a more complicated interaction between fluid status and blood pressure.
Questions About Lozol
Is Lozol the same as Microzide? No. Both can lower blood pressure, but they have distinct drug substances and doses.
Are 1.5 mg and 2.5 mg interchangeable? Not without checking the release system and the prescription.
Can it cause leg cramps? Low potassium or other changes may contribute and deserve assessment.
Why should sodium be measured? Thiazide-like drugs can produce hyponatremia, particularly in susceptible patients.
Does the timing matter? Follow the product schedule, accounting for increased urination or postural symptoms.





